Middle East Pharmaceutical Industries Company

SASE:4016 Stock Report

Market Cap: ر.س2.7b

Middle East Pharmaceutical Industries Future Growth

Future criteria checks 1/6

Middle East Pharmaceutical Industries is forecast to grow revenue at 13.3% per annum.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth17.1%
Revenue growth rate13.3%
Future return on equityn/a
Analyst coverage

Low

Last updated08 Sep 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

SASE:4016 - Analysts future estimates and past financials data (SAR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026510N/AN/AN/A1
12/31/2025446N/AN/AN/A1
12/31/2024385N/AN/AN/A1
6/30/20243677973104N/A
3/31/20243597671104N/A
12/31/2023338666293N/A
9/30/2023328636492N/A
6/30/2023318596691N/A
3/31/2023291506284N/A
12/31/2022303594869N/A
12/31/2021287661641N/A
12/31/202030273544N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 4016's forecast earnings growth is above the savings rate (14.5%).

Earnings vs Market: Insufficient data to determine if 4016's earnings are forecast to grow faster than the SA market

High Growth Earnings: Insufficient data to determine if 4016's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 4016's revenue (13.3% per year) is forecast to grow faster than the SA market (1.3% per year).

High Growth Revenue: 4016's revenue (13.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 4016's Return on Equity is forecast to be high in 3 years time


Discover growth companies